HIV is infamous for its ability to hide in the human body for decades, typically requiring long-term treatment to prevent a ...

Merck's two-drug HIV regimen doravirine/islatravir maintained viral suppression and matched Gilead's Biktarvy in Phase 3 ...

Among patients with late diagnosed HIV infection, the choice of a two- or three-drug regimen is not associated with 48 week ...

The American South has the highest HIV rates in the country, accounting for more than half of new HIV diagnoses nationwide in ...

There was no significant difference in virologic efficacy through 96 weeks in adults with HIV who switched to DTG/3TC vs ...

When diagnosed with HIV, the timing of treatment initiation can significantly impact long-term health outcomes and quality of life. Medical experts increasingly advocate for immediate treatment ...

Funding cuts for research intended to make treatment and cures available and accessible for patients with HIV could affect HIV care in the long term.

Cuts proposed by the Trump administration and House Republicans could drive up new HIV cases by more than 200,000 by 2030, ...

South Africa has welcomed a U.S. bridging plan worth $115 million to continue funding HIV treatment and prevention programs ...

Community advocates, health providers and local leaders in Charleston are all joining forces Wednesday in observance of ...